Merrimack Pharmaceuticals logo
Merrimack Pharmaceuticals MACK
$ 15.13 0.0%

Quarterly report 2024-Q1
added 05-15-2024

report update icon

Merrimack Pharmaceuticals EV/EBITDA Ratio 2011-2024 | MACK

Annual EV/EBITDA Ratio Merrimack Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-27 -17.3 -0.991 -0.846 -0.243 -5.07 -4.89 -13.6 -4.03 -3.97 -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-0.243 -27 -7.8